112 related articles for article (PubMed ID: 10983856)
1. Improvement of in vivo stability of phosphodiester oligonucleotide using anionic liposomes in mice.
De Oliveira MC; Boutet V; Fattal E; Boquet D; Grognet JM; Couvreur P; Deverre JR
Life Sci; 2000 Aug; 67(13):1625-37. PubMed ID: 10983856
[TBL] [Abstract][Full Text] [Related]
2. pH-sensitive liposomes as a carrier for oligonucleotides: a physico-chemical study of the interaction between DOPE and a 15-mer oligonucleotide in excess water.
de Oliveira MC; Rosilio V; Lesieur P; Bourgaux C; Couvreur P; Ollivon M; Dubernet C
Biophys Chem; 2000 Oct; 87(2-3):127-37. PubMed ID: 11099176
[TBL] [Abstract][Full Text] [Related]
3. pH-sensitive liposomes as a carrier for oligonucleotides: a physico-chemical study of the interaction between DOPE and a 15-mer oligonucleotide in quasi-anhydrous samples.
De Oliveira MC; Fattal E; Couvreur P; Lesieur P; Bourgaux C; Ollivon M; Dubernet C
Biochim Biophys Acta; 1998 Jul; 1372(2):301-10. PubMed ID: 9675320
[TBL] [Abstract][Full Text] [Related]
4. In vivo delivery of antisense oligonucleotides in pH-sensitive liposomes inhibits lipopolysaccharide-induced production of tumor necrosis factor-alpha in rats.
Ponnappa BC; Dey I; Tu GC; Zhou F; Aini M; Cao QN; Israel Y
J Pharmacol Exp Ther; 2001 Jun; 297(3):1129-36. PubMed ID: 11356938
[TBL] [Abstract][Full Text] [Related]
5. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route.
Hattori Y; Suzuki S; Kawakami S; Yamashita F; Hashida M
J Control Release; 2005 Nov; 108(2-3):484-95. PubMed ID: 16181701
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and immunotargetability of ganglioside-stabilized dioleoylphosphatidylethanolamine liposomes.
Litzinger DC; Huang L
Biochim Biophys Acta; 1992 Feb; 1104(1):179-87. PubMed ID: 1550846
[TBL] [Abstract][Full Text] [Related]
7. "Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes.
Fattal E; Couvreur P; Dubernet C
Adv Drug Deliv Rev; 2004 Apr; 56(7):931-46. PubMed ID: 15066753
[TBL] [Abstract][Full Text] [Related]
8. Fate of cationic liposomes and their complex with oligonucleotide in vivo.
Litzinger DC; Brown JM; Wala I; Kaufman SA; Van GY; Farrell CL; Collins D
Biochim Biophys Acta; 1996 Jun; 1281(2):139-49. PubMed ID: 8664312
[TBL] [Abstract][Full Text] [Related]
9. Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides.
Dheur S; Dias N; van Aerschot A; Herdewijn P; Bettinger T; Rémy JS; Hélène C; Saison-Behmoaras ET
Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):515-25. PubMed ID: 10645777
[TBL] [Abstract][Full Text] [Related]
10. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin.
Zuidam NJ; Barenholz Y
Biochim Biophys Acta; 1997 Oct; 1329(2):211-22. PubMed ID: 9371413
[TBL] [Abstract][Full Text] [Related]
11. Improved formulations of antisense oligodeoxynucleotides using wrapped liposomes.
Yamauchi M; Kusano H; Saito E; Iwata T; Nakakura M; Kato Y; Uochi T; Akinaga S; Aoki N
J Control Release; 2006 Aug; 114(2):268-75. PubMed ID: 16860428
[TBL] [Abstract][Full Text] [Related]
12. Enhanced delivery of synthetic oligonucleotides to human leukaemic cells by liposomes and immunoliposomes.
Ma DD; Wei AQ
Leuk Res; 1996; 20(11-12):925-30. PubMed ID: 9009250
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics and tissue distribution of long circulating liposomes in rabbits and mice].
Ma C; Kuang AR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):249-51, 268. PubMed ID: 21500565
[TBL] [Abstract][Full Text] [Related]
14. Amphipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in spleen.
Litzinger DC; Huang L
Biochim Biophys Acta; 1992 Aug; 1127(3):249-54. PubMed ID: 1511002
[TBL] [Abstract][Full Text] [Related]
15. Fusogenic pH sensitive liposomal formulation for rapamycin: improvement of antiproliferative effect.
Ghanbarzadeh S; Khorrami A; Mohamed Khosroshahi L; Arami S
Pharm Biol; 2014 Jul; 52(7):848-54. PubMed ID: 24920230
[TBL] [Abstract][Full Text] [Related]
16. Biological effects and cellular uptake of c-myc antisense oligonucleotides and their cationic liposome complexes.
Kanamaru T; Takagi T; Takakura Y; Hashida M
J Drug Target; 1998; 5(4):235-46. PubMed ID: 9713974
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of cholesterol modified cationic lipids for liposomal drug delivery of antisense oligonucleotides.
Zimmer A; Aziz SA; Gilbert M; Werner D; Noe CR
Eur J Pharm Biopharm; 1999 Mar; 47(2):175-8. PubMed ID: 10234543
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of stealth versus conventional liposomes: effect of dose.
Allen TM; Hansen C
Biochim Biophys Acta; 1991 Sep; 1068(2):133-41. PubMed ID: 1911826
[TBL] [Abstract][Full Text] [Related]
19. Delivery of phosphodiester oligonucleotides: can DOTAP/DOPE liposomes do the trick?
Remaut K; Lucas B; Braeckmans K; Sanders NN; Demeester J; De Smedt SC
Biochemistry; 2006 Feb; 45(6):1755-64. PubMed ID: 16460022
[TBL] [Abstract][Full Text] [Related]
20. Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy.
Krieg AM; Tonkinson J; Matson S; Zhao Q; Saxon M; Zhang LM; Bhanja U; Yakubov L; Stein CA
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1048-52. PubMed ID: 8430072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
